Literature DB >> 25975647

5-azacytidine promotes terminal differentiation of hepatic progenitor cells.

Yun He1, Jiejie Cui2, Tongchuan He2, Yang Bi1.   

Abstract

5-azacytidine (5-azaC) is known to induce cardiomyocyte differentiation. However, its function in hepatocyte differentiation is unclear. The present study investigated the in vitro capability of 5-azaC to promote maturation and differentiation of mouse embryonic hepatic progenitor cells, with the aim of developing an approach for improving hepatic differentiation. Mouse embryonic hepatic progenitor cells (HP14.5 cells) were treated with 5-azaC at concentrations from 0 to 20 μmol/l, in addition to hepatocyte induction culture medium. Hepatocyte induction medium induces HP14.5 cell differentiation. 5-azaC may enhance the albumin promotor-driven Gaussia luciferase (ALB-GLuc) activity in induced HP14.5 cells. In the present study 2 μmol/l was found to be the optimum concentration with which to achieve this. The expression of hepatocyte-associated factors was not significantly different between the group treated with 5-azaC alone and the control group. The mRNA levels of ALB; cytokeratin 18 (CK18); tyrosine aminotransferase (TAT); and cytochrome p450, family 1, member A1 (CYP1A1); in addition to the protein levels of ALB, CK18 and uridine diphosphate glucuronyltransferase 1A (UGT1A) in the induced group with 5-azaC, were higher than those in the induced group without 5-azaC, although no significant differences were detected in expression of the hepatic stem cell markers, DLK and α-fetoprotein, between the two groups. Treatment with 5-azaC alone did not affect glycogen synthesis or indocyanine green (ICG) metabolic function in HP14.5 cells, although it significantly increased ICG uptake and periodic acid-Schiff-positive cell numbers amongst HP14.5 cells. Therefore, the present study demonstrated that treatment with 5-azaC alone exerted no effects on the maturation and differentiation of HP14.5 cells. However, 5-azaC exhibited a synergistic effect on the terminal differentiation of induced hepatic progenitor cells in association with a hepatic induction medium.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25975647     DOI: 10.3892/mmr.2015.3772

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  5 in total

1.  Periodic acid‑Schiff staining method for function detection of liver cells is affected by 2% horse serum in induction medium.

Authors:  Hui Hui; Wenjun Ma; Jiejie Cui; Mengjia Gong; Yi Wang; Yuanyuan Zhang; Tongchuan He; Yang Bi; Yun He
Journal:  Mol Med Rep       Date:  2017-09-22       Impact factor: 2.952

2.  Hepatogenic Potential and Liver Regeneration Effect of Human Liver-derived Mesenchymal-Like Stem Cells.

Authors:  Jooyoung Lee; Jiwan Choi; Seoon Kang; Jiye Kim; Ryunjin Lee; Seongjun So; Young-In Yoon; Varvara A Kirchner; Gi-Won Song; Shin Hwang; Sung-Gyu Lee; Eunju Kang; Eunyoung Tak
Journal:  Cells       Date:  2020-06-22       Impact factor: 6.600

3.  Zebularine Promotes Hepatic Differentiation of Rabbit Bone Marrow Mesenchymal Stem Cells by Interfering with p38 MAPK Signaling.

Authors:  Yong-Heng Luo; Juan Chen; En-Hua Xiao; Qiu-Yun Li; Yong-Mei Luo
Journal:  Stem Cells Int       Date:  2018-10-10       Impact factor: 5.443

4.  Differentiation Therapy by Epigenetic Reconditioning Exerts Antitumor Effects on Liver Cancer Cells.

Authors:  Luc Gailhouste; Lee Chuen Liew; Ken Yasukawa; Izuho Hatada; Yasuhito Tanaka; Hitoshi Nakagama; Takahiro Ochiya
Journal:  Mol Ther       Date:  2018-04-26       Impact factor: 11.454

5.  All-trans retinoic acid reverses malignant biological behavior of hepatocarcinoma cells by regulating miR-200 family members.

Authors:  Jiejie Cui; Mengjia Gong; Shuyu Fang; Chaoqun Hu; Yi Wang; Jingfang Zhang; Ni Tang; Yun He
Journal:  Genes Dis       Date:  2020-01-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.